title: Erratum to: Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
abstract: Erratum to: Cancer Chemother Pharmacol (2014), 74:1139–1147, DOI 10.1007/s00280‑014‑2586‑6. Unfortunately, the part of acknowledgement detail was omitted in the published article and the below line must be considered as the last sentence: "This study is a Turkish Oncology Group trial".
authors.affiliation: Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
authors.forename: Nuriye
authors.initials: N
authors.lastname: Ozdemir
authors.forename: Huseyin
authors.initials: H
authors.lastname: Abali
authors.forename: Murat
authors.initials: M
authors.lastname: Vural
authors.forename: Suayib
authors.initials: S
authors.lastname: Yalcin
authors.forename: Berna
authors.initials: B
authors.lastname: Oksuzoglu
authors.forename: Burak
authors.initials: B
authors.lastname: Civelek
authors.forename: Dilek
authors.initials: D
authors.lastname: Oguz
authors.forename: Birol
authors.initials: B
authors.lastname: Bostanci
authors.forename: Bulent
authors.initials: B
authors.lastname: Yalcin
authors.forename: Nurullah
authors.initials: N
authors.lastname: Zengin